Sangart
Industry · 10 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Phase 2c Dose Comparison Study of MP4OX in Trauma Trauma, Hemorrhagic Shock, Lactic Acidosis | Phase 2 | 2013-12-01 |
| Withdrawn | Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis Anemia, Sickle Cell, Sickle Cell Anemia, Sickle Cell Disease | Phase 2 | 2013-10-01 |
| Completed | Safety Study of MP4CO in Adult Sickle Cell Patients Anemia, Sickle Cell, Sickle Cell Anemia, Sickle Cell Disease | Phase 1 | 2012-01-01 |
| Completed | Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients Shock, Hemorrhagic, Shock, Traumatic, Acidosis, Lactic | Phase 2 | 2011-05-01 |
| Completed | Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients Shock, Hemorrhagic, Shock, Traumatic, Acidosis, Lactic | Phase 2 | 2009-12-01 |
| Completed | Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia Vascular Disease, Critical Lower Limb Ischemia | Phase 2 | 2007-09-01 |
| Completed | Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty Hypotension, Ischemia | Phase 3 | 2007-02-01 |
| Completed | Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty Hypotension, Ischemia | Phase 3 | 2007-02-01 |
| Completed | Safety Study of Hemospan® in Prostatectomy Patients Blood Loss, Surgical, Prostate Cancer, Surgery | Phase 2 | 2005-07-01 |
| Completed | Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients Hypotension, Hypoxia | Phase 1 / Phase 2 | 2003-04-01 |